Posts Tagged
Science
Home
Blog
Science
15
Jan 2021
ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients
Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.
11
Dec 2020
BenevolentAI wins Innovation Award at 2020 Scrip Awards
BenevolentAI wins the Innovation Award at the prestigious 2020 Scrip Awards for our work in artificial intelligence applied drug discovery.
13
Nov 2020
Data published in Science Advances shows baricitinib reduces COVID-19 morbidity and mortality
Research published in Science Advances supports BenevolentAI’s AI-generated hypothesis from late January for baricitinib as a treatment for COVID-19.
11
Nov 2020
Investival Showcase Virtual w/ Jackie Hunter
Join BenevolentAI’s Board Director, Jackie Hunter, at the Investival Showcase for a discussion of cross-sector approaches to solving healthcare’s biggest challenges.
Next Page
More Tags
Data Diversity
Featured
Life
Opinion
Press Release
Technology
Categories
Blog
Events
News
Video
OUr Work
WHAT WE DO
DRUG PROGRAMMES
Why it matters
about us
Join us
research
News